Cite

HARVARD Citation

    Hassan, R. et al. (n.d.). 87 Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM). Lung cancer. pp. S31-S32. [Online]. 
  
Back to record